Have a personal or library account? Click to login
The assessment of parameters of convalescent plasma and their impact on COVID-19 symptoms Cover

The assessment of parameters of convalescent plasma and their impact on COVID-19 symptoms

Postępy Higieny i Medycyny Doświadczalnej
Volume 79 (2025): Issue 1 (January 2025)
By: Agnieszka Kuś,  Szymon Wieczorek,  Jarosław Dybko,  Małgorzata Szymczyk-Nużka,  Aleksandra Butrym,  Krzysztof Dudek,  Grzegorz Mazur and  Siddarth Agrawal  
Open Access
|Apr 2025

References

  1. COVID-19 Map - Johns Hopkins Coronavirus Resource Center 2021. Available at: https://coronavirus.jhu.edu/map.html (Accessed November 06, 2022).
    Search in Google ScholarBack to article
  2. Fischer JC, Zänker K, Van Griensven M, Schneider M, Kindgen-Milles D, Knoefel WT, Lichtenberg A, Tamaskovics B, Djiepmo-Njanang FJ, Budach W, et al. The role of passive immunization in the age of SARS-CoV-2: An update. European Journal of Medical Research. 2020;25(1).
    Search in Google ScholarBack to article
  3. Centers for Disease Control and Prevention (CDC). COVID-19 Treatments and Medications 2022. Available at: https://archive.cdc.gov/www_cdc_gov/coronavirus/2019-ncov/your-health/treatments-for-severe-illness.html (Accessed November 06, 2022).
    Search in Google ScholarBack to article
  4. Franchini M, Glingani C, De Donno G, Lucchini G, Beccaria M, Amato M, Castelli GP, Bianciardi L, Pagani M, Ghirardini M, et al. Convalescent plasma for hospitalized COVID-19 patients: A single-center experience. Life. 2022;12(3).
    Search in Google ScholarBack to article
  5. Tobaiqy M, Qashqary M, Al-Dahery S, Mujallad A, Hershan AA, Kamal MA, Helmi N. Therapeutic management of patients with COVID-19: a systematic review. Infection Prevention in Practice. 2020;2(3).
    Search in Google ScholarBack to article
  6. Heustess AM, Allard MA, Thompson DK, Fasinu PS. Clinical management of covid-19: A review of pharmacological treatment options. Pharmaceuticals. 2021;14(6).
    Search in Google ScholarBack to article
  7. Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS, Makki S, Rooney KD, Nguyen-Van-Tam JS, Beck CR, et al. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: A systematic review and exploratory meta-analysis. Journal of Infectious Diseases. 2015;211(1):80–90.
    Search in Google ScholarBack to article
  8. Marconato M, Abela IA, Hauser A, Schwarzmüller M, Katzensteiner R, Braun DL, Epp S, Audigé A, Weber J, Rusert P, et al. Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response. Journal of Clinical Investigation. 2022;132(12).
    Search in Google ScholarBack to article
  9. Zhou B, Zhong N, Guan Y. Treatment with convalescent plasma for influenza A (H5N1) infection. New England Journal of Medicine. 2007;357(14):1450–1.
    Search in Google ScholarBack to article
  10. Ko JH, Seok H, Cho SY, Ha YE, Baek JY, Kim SH, Kim YJ, Park JK, Chung CR, Kang ES, et al. Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: A single centre experience. Antiviral Therapy. 2018;23(7):617–22.
    Search in Google ScholarBack to article
  11. Cheng Y, Wong R, Soo YOY, Wong WS, Lee CK, Ng MHL, Chan P, Wong KC, Leung CB, Cheng G. Use of convalescent plasma therapy in SARS patients in Hong Kong. European Journal of Clinical Microbiology and Infectious Diseases. 2005;24(1):44–6.
    Search in Google ScholarBack to article
  12. Hung IFN, To KKW, Lee CK, Lee KL, Chan K, Yan WW, Liu R, Watt CL, Chan WM, Lai KY, et al. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clinical Infectious Diseases. 2011;52(4):447–56.
    Search in Google ScholarBack to article
  13. van Griensven J, Edwards T, de Lamballerie X, Semple MG, Gallian P, Baize S, Horby PW, Raoul H, Magassouba N, Antierens A, et al. Evaluation of convalescent plasma for ebola virus disease in Guinea. New England Journal of Medicine. 2016;374(1):33–42.
    Search in Google ScholarBack to article
  14. Marano G, Vaglio S, Pupella S, Facco G, Catalano L, Liumbruno GM, Grazzini G. Convalescent plasma: New evidence for an old therapeutic tool? Blood Transfusion. 2016;14(2):152–7.
    Search in Google ScholarBack to article
  15. Joyner MJ, Wright RS, Fairweather D, Senefeld JW, Bruno KA, Klassen SA, Carter RE, Klompas AM, Wiggins CC, Shepherd JRA, et al. Early safety indicators of COVID-19 convalescent plasma in 5000 patients. Journal of Clinical Investigation. 2020;130(9):4791–7.
    Search in Google ScholarBack to article
  16. World Health Organization (WHO). IMAI District Clinician Manual: Hospital care for adolescents and adults. World Health Organization. 2011;2(January):780.
    Search in Google ScholarBack to article
  17. Müller-Olling M, Vahlensieck U, Hilger A. Heterogeneity in COVID-19 convalescent plasma clinical trials. Clinical Pharmacology and Therapeutics. 2022;111(5):995–1000.
    Search in Google ScholarBack to article
  18. Lünemann JD, Nimmerjahn F, Dalakas MC. Intravenous immunoglobulin in neurology-mode of action and clinical efficacy. Nature Reviews Neurology. 2015;11(2):80–9.
    Search in Google ScholarBack to article
  19. Khan TNS, Mukry SN, Masood S, Meraj L, Devrajani BR, Akram J, Fatima N, Maqsood S, Mahesar A, Siddiqui R, et al. Usefulness of convalescent plasma transfusion for the treatment of severely ill COVID-19 patients in Pakistan. BMC Infectious Diseases. 2021;21(1).
    Search in Google ScholarBack to article
  20. Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, Zhou M, Chen L, Meng S, Hu Y, et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proceedings of the National Academy of Sciences of the United States of America. 2020;117(17):9490–6.
    Search in Google ScholarBack to article
  21. Alsharidah S, Ayed M, Ameen RM, Alhuraish F, Rouheldeen NA, Alshammari FR, Embaireeg A, Almelahi M, Adel M, Dawoud ME, et al. COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: A multicenter interventional study. International Journal of Infectious Diseases. 2021;103:439–46.
    Search in Google ScholarBack to article
  22. Franchini M, Glingani C, Morandi M, Corghi G, Cerzosimo S, Beduzzi G, Storti A, Di Stasi V, Rastrelli G, Vignozzi L, et al. Safety and efficacy of convalescent plasma in elderly COVID-19 patients: The RESCUE trial. Mayo Clinic Proceedings: Innovations, Quality & Outcomes. 2021;5(2):403–12.
    Search in Google ScholarBack to article
  23. Xu TM, Lin B, Chen C, Liu LG, Xue Y. Non-optimal effectiveness of convalescent plasma transfusion and hydroxychloroquine in treating COVID-19: A case report. Virology Journal. 2020;17(1).
    Search in Google ScholarBack to article
  24. Joyner MJ, Senefeld JW, Klassen SA, Mills JR, Johnson PW, Theel ES, Wiggins CC, Bruno KA, Klompas AM, Lesser ER, et al. Effect of convalescent plasma on mortality among hospitalized patients with COVID-19: Initial three-month experience. medRxiv: the preprint server for health sciences. 2020.
    Search in Google ScholarBack to article
  25. Arrieta A, Galvis AE, Morphew T, Ehwerhemuepha L, Osborne S, Enriquez C, Imfeld K, Hoang J, Nieves D, Ashouri N, et al. Safety and antibody kinetics of COVID-19 convalescent plasma for the treatment of moderate to severe cases of SARS-COV-2 infection in pediatric patients. Pediatric Infectious Disease Journal. 2021;40(7):606–11.
    Search in Google ScholarBack to article
  26. Kuś A, Wieczorek S, Dybko J, Szymczyk-Nużka M, Butrym A, Makuch S, Mazur G, Agrawal S. Potential of high-titre IgA convalescent plasma to improve survival and symptoms in COVID-19 patients. European Journal of Clinical Investigation. 2023;53(2):13928.
    Search in Google ScholarBack to article
  27. Verkerke H, Saeedi BJ, Boyer D, Allen JW, Owens J, Shin S, Horwath M, Patel K, Paul A, Wu SC, et al. Are we forgetting about IgA? A re-examination of coronavirus disease 2019 convalescent plasma. Transfusion. 2021;61(6):1740–8.
    Search in Google ScholarBack to article
  28. Ghadami L, Hasibi M, Asadollahi-Amin A, asanjarani B, Farahmand M, Abdollahi H. Convalescent plasma therapy in patients with severe COVID-19, A single-arm, retrospective study. Microbial Pathogenesis. 2022;165.
    Search in Google ScholarBack to article
  29. Wang X, Guo X, Xin Q, Pan Y, Hu Y, Li J, Chu Y, Feng Y, Wang Q. Neutralizing antibody responses to severe acute respiratory syndrome coronavirus 2 in coronavirus disease 2019 inpatients and convalescent patients. Clinical Infectious Diseases. 2020;71(10):2688–94.
    Search in Google ScholarBack to article
  30. Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, Liu S, Yang JK. Gender differences in patients with COVID-19: Focus on severity and mortality. Frontiers in Public Health. 2020;8.
    Search in Google ScholarBack to article
  31. Schmidt AE, Vogel P, Chastain CA, Barnes T, Roth NJ, Simon TL. Analysis of 52 240 source plasma donors of convalescent COVID-19 plasma: Sex, ethnicity, and age association with initial antibody levels and rate of dissipation. Journal of Clinical Apheresis. 2022;37(5):449–59.
    Search in Google ScholarBack to article
  32. Jain S, Garg K, Tran SM, Rask IL, Tarczon M, Nandi V, Kessler DA, Strauss D, Sachais BS, Yazdanbakhsh K, et al. Characteristics of coronavirus disease 19 convalescent plasma donors and donations in the New York metropolitan area. Transfusion. 2021;61(8):2374–83.
    Search in Google ScholarBack to article
  33. Mehew J, Johnson R, Roberts D, Harvala H. Convalescent plasma for COVID-19: Male gender, older age and hospitalisation associated with high neutralising antibody levels, England, 22 April to 12 May 2020. Eurosurveillance. 2020;25(45).
    Search in Google ScholarBack to article
  34. Fairweather DL, Rose NR. Women and autoimmune diseases. Emerging Infectious Diseases. 2004;10(11):2005–11.
    Search in Google ScholarBack to article
  35. Foo YZ, Nakagawa S, Rhodes G, Simmons LW. The effects of sex hormones on immune function: a meta-analysis. Biological Reviews. 2017;92(1):551–71.
    Search in Google ScholarBack to article
  36. Rahimi-Levene N, Shapira J, Tzur I, Shiloah E, Peer V, Levin E, Izak M, Shinar E, Ziv-Baran T, Weinberger M, et al. Predictors of mortality in COVID-19 patients treated with convalescent plasma therapy. PLoS ONE. 2022;17(7 July).
    Search in Google ScholarBack to article
  37. Bloch EM, Shoham S, Casadevall A, Sachais BS, Shaz B, Winters JL, Van Buskirk C, Grossman BJ, Joyner M, Henderson JP, et al. Deployment of convalescent plasma for the prevention and treatment of COVID-19. Journal of Clinical Investigation. 2020;130(6):2757–65.
    Search in Google ScholarBack to article
  38. Hartmann J, Bloch EM, Burnouf T. Experience with COVID-19 convalescent plasma provides vital guidance to future pandemics. Transfusion. 2022;62(3):681–4.
    Search in Google ScholarBack to article
DOI: https://doi.org/10.2478/ahem-2025-0006 | Journal eISSN: 1732-2693
Journal RSS Feed
Language: English
Page range: 35 - 49
Submitted on: Jul 29, 2024
|
Accepted on: Feb 19, 2025
|
Published on: Apr 17, 2025
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
plasma transfusion,
COVID-19,
convalescent plasma,
anti-SARS-CoV-2 neutralization antibodies,
serologic parameters
Related subjects:
Life sciences,
Molecular biology,
Microbiology and virology,
Medicine,
Basic medical science,
Immunology

© 2025 Agnieszka Kuś, Szymon Wieczorek, Jarosław Dybko, Małgorzata Szymczyk-Nużka, Aleksandra Butrym, Krzysztof Dudek, Grzegorz Mazur, Siddarth Agrawal, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 79 (2025): Issue 1 (January 2025)Next article